Shandong Jincheng Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Shandong Jincheng Pharmaceutical Group has a total shareholder equity of CN¥3.8B and total debt of CN¥599.5M, which brings its debt-to-equity ratio to 15.8%. Its total assets and total liabilities are CN¥5.7B and CN¥1.9B respectively. Shandong Jincheng Pharmaceutical Group's EBIT is CN¥233.5M making its interest coverage ratio 47.5. It has cash and short-term investments of CN¥1.1B.
Key information
15.8%
Debt to equity ratio
CN¥599.47m
Debt
| Interest coverage ratio | 47.5x |
| Cash | CN¥1.07b |
| Equity | CN¥3.80b |
| Total liabilities | CN¥1.94b |
| Total assets | CN¥5.74b |
Recent financial health updates
Recent updates
Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Popularity With Investors Is Under Threat From Overpricing
Jun 07
Shandong Jincheng Pharmaceutical Group's (SZSE:300233) Problems Go Beyond Weak Profit
Apr 04Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Climb 29% But Its Business Is Yet to Catch Up
Mar 04Shandong Jincheng Pharmaceutical Group (SZSE:300233) Seems To Use Debt Quite Sensibly
Mar 02Financial Position Analysis
Short Term Liabilities: 300233's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300233's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥513.5M).
Debt to Equity History and Analysis
Debt Level: 300233 has more cash than its total debt.
Reducing Debt: 300233's debt to equity ratio has increased from 12.3% to 15.8% over the past 5 years.
Debt Coverage: 300233's debt is well covered by operating cash flow (93%).
Interest Coverage: 300233's interest payments on its debt are well covered by EBIT (47.5x coverage).